2C-T-19

Template:Short description Template:Template other{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals= | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=142312COc1cc(SCCCC)c(cc1CCN)OC1S/C14H23NO2S/c1-4-5-8-18-14-10-12(16-2)11(6-7-15)9-13(14)17-3/h9-10H,4-8,15H2,1-3H3LGUVDOBGXUFUAJ-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data= None | _legal_data=

| _other_data=2-[4-(butylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine

| _image_0_or_2 = 2C-T-192DACS.svg2C-T-19-3d-sticks.png | _image_LR =

| _datapage = 2C-T-19 (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental=None | _has_EMA_link = | CAS_number=732244-33-6 | PubChem=12063257 | ChemSpiderID=21106235 | ChEBI= | ChEMBL= | DrugBank= | KEGG= | _hasInChI_or_Key=yes | UNII=H190WE556H | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs= | _countIndexlabels= | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields= |verifiedrevid=399302729}}

2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.

Use and effects

In his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.

Society and culture

Legal status

Canada

As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.

United States

In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

See also

• 2C (psychedelics)

External links

• 2C-T-19 - Isomer Design